X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (19) 19
humans (16) 16
female (15) 15
hematology (15) 15
middle aged (15) 15
oncology (15) 15
male (14) 14
aged (13) 13
cancer (13) 13
adult (12) 12
life sciences (12) 12
lymphomas (10) 10
rituximab (10) 10
antineoplastic combined chemotherapy protocols - therapeutic use (9) 9
chemotherapy (9) 9
aged, 80 and over (8) 8
lymphoma (8) 8
treatment outcome (7) 7
care and treatment (6) 6
retrospective studies (6) 6
[sdv.can]life sciences [q-bio]/cancer (5) 5
adolescent (5) 5
analysis (5) 5
disease-free survival (5) 5
management (5) 5
relapse (5) 5
therapy (5) 5
transplantation (5) 5
[sdv]life sciences [q-bio] (4) 4
antineoplastic agents - therapeutic use (4) 4
combined modality therapy (4) 4
follow-up (4) 4
patients (4) 4
response criteria (4) 4
survival (4) 4
survival analysis (4) 4
trial (4) 4
young adult (4) 4
[ sdv.can ] life sciences [q-bio]/cancer (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
b-cell lymphoma (3) 3
central nervous system (3) 3
drug administration schedule (3) 3
follow-up studies (3) 3
hematology, oncology and palliative medicine (3) 3
hemic and lymphatic diseases (3) 3
medical research (3) 3
medicine, experimental (3) 3
methotrexate (3) 3
primary cns lymphoma (3) 3
prognosis (3) 3
radiotherapy (3) 3
recurrence (3) 3
remission induction (3) 3
safety (3) 3
stem cell transplantation (3) 3
stem cells (3) 3
survival rate (3) 3
1st-line treatment (2) 2
[ sdv ] life sciences [q-bio] (2) 2
angiogenesis (2) 2
antibodies, monoclonal, murine-derived - administration & dosage (2) 2
antimitotic agents (2) 2
antineoplastic agents (2) 2
article (2) 2
autografts (2) 2
bone marrow (2) 2
combination (2) 2
consolidation (2) 2
cyclophosphamide (2) 2
cytarabine (2) 2
cytarabine - administration & dosage (2) 2
dasatinib (2) 2
double-blind (2) 2
drug resistance, neoplasm (2) 2
efficacy (2) 2
elderly-patients (2) 2
epistaxis (2) 2
era (2) 2
experience (2) 2
follicular lymphoma (2) 2
france (2) 2
geriatrics (2) 2
hema10 (2) 2
hodgkin disease - mortality (2) 2
hodgkin lymphoma (2) 2
hodgkin's disease (2) 2
human health and pathology (2) 2
ibrutinib (2) 2
immune system diseases (2) 2
immunotherapy (2) 2
interferon-alpha (2) 2
international prognostic index (2) 2
kaplan-meier estimate (2) 2
lymphocytic leukemia (2) 2
lymphoma - drug therapy (2) 2
lymphoma, follicular - drug therapy (2) 2
lymphoma, follicular - mortality (2) 2
lymphoma, large b-cell, diffuse - diagnostic imaging (2) 2
lymphoma, large b-cell, diffuse - drug therapy (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
British Journal of Haematology, ISSN 0007-1048, 10/2018, Volume 183, Issue 1, pp. 76 - 86
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 4215 - 4215
Abstract Introduction: standard treatment for relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) is high-dose chemotherapy followed by autologous... 
Journal Article
British Journal of Haematology, ISSN 0007-1048, 09/2018, Volume 182, Issue 6, pp. 807 - 815
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 4612 - 4612
Abstract Introduction: high dose chemotherapy (HDT) and autologous stem cell transplantation (ASCT) is an effective treatment in relapsed follicular lymphoma... 
Journal Article
Journal of Neuro-Oncology, ISSN 0167-594X, 6/2017, Volume 133, Issue 2, pp. 315 - 320
Journal Article
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 1549 - 1549
Introduction Patients with relapsed/refractory Hodgkin lymphoma (R/R HL) experience high response rates upon anti-PD1 therapy. In these patients, the optimal... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 2014, Volume 32, Issue 10, pp. 1066 - 1073
Journal Article
Leukemia, ISSN 0887-6924, 08/2019
We report assessment of minimal residual disease (MRD) status and its association with outcome in rituximab-refractory follicular lymphoma (FL) in the... 
Journal Article
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 688 - 688
Abstract Introduction: Pneumocystis jirovecii (Pj) is an opportunistic fungus and a common cause of pneumonia (PCP) in immunocompromised patient. The gold... 
Journal Article